CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-13 | OLUKOTUN ADEOYE Y Director | Sale | −2,750 | $63.76 | $175K | 9,000 |
| 2021-09-09 | GIVEN DOUGLAS B Director | Sale | −5,000 | $65.24 | $326K | 109,868 |
| 2021-06-24 | De Backer Marianne Director | Sale | −5,000 | $89.85 | $449K | 21,500 |
| 2021-06-22 | Hassard James Chief Commercial Officer | Sale | −3,625 | $89.22 | $323K | 105,750 |
| 2021-06-22 | GIVEN DOUGLAS B Director | Sale | −4,500 | $89.21 | $401K | 114,868 |
| 2021-02-22 | GIVEN DOUGLAS B Director | Sale | −1,125 | $88.73 | $100K | 13,875 |
| 2021-02-08 | O'Brien Patrick General Counsel | Option exercise | +90,000 | $5.22 | $470K | 383,375 |
| 2021-02-08 | O'Brien Patrick General Counsel | Sale | −7,961 | $86.72 | $690K | 375,414 |
| 2021-02-08 | O'Brien Patrick General Counsel | Sale | −31,255 | $88.08 | $2.8M | 344,159 |
| 2021-02-08 | O'Brien Patrick General Counsel | Sale | −45,348 | $88.88 | $4.0M | 298,811 |
| 2021-02-08 | O'Brien Patrick General Counsel | Sale | −5,436 | $89.66 | $487K | 293,375 |
| 2021-02-08 | O'Brien Patrick General Counsel | Option exercise · Stock Option (right to buy) | −90,000 | 60,000 | ||
| 2021-01-15 | GIVEN DOUGLAS B Director | Sale | −3,000 | $83.28 | $250K | 12,500 |
| 2021-01-14 | Hamilton James C Senior Vice President | Sale | −6,186 | $80.97 | $501K | 130,064 |
| 2021-01-14 | Hamilton James C Senior Vice President | Sale | −3,814 | $81.82 | $312K | 126,250 |
| 2021-01-12 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −1,441 | $81.00 | $117K | 444,005 |
| 2021-01-11 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −11,597 | $81.02 | $940K | 445,446 |
| 2021-01-07 | Hassard James Chief Commercial Officer | Sale | −15,625 | $75.00 | $1.2M | 109,375 |
| 2021-01-06 | O'Brien Patrick General Counsel | Sale | −1,142 | $70.78 | $81K | 317,233 |
| 2021-01-06 | O'Brien Patrick General Counsel | Sale | −10,615 | $72.27 | $767K | 306,618 |
Page 18 of 38 · 752 trades